Twist Bioscience Corp Industry Peers
Companies in the Biotechnology industry
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Biotechnology
76 companies in this industry (including TWST)
Sector: Health Care
Other Companies in Biotechnology
| Company | Revenue | Profit Margin | ROE |
|---|---|---|---|
| AbbVie(ABBV) | $59.64B | 4.0% | - |
| Amgen(AMGN) | $35.97B | 19.5% | 72.8% |
| Gilead Sciences(GILD) | $29.09B | 27.9% | 37.6% |
| Regeneron Pharmaceuticals(REGN) | $14.25B | 32.1% | 14.8% |
| Vertex Pharmaceuticals(VRTX) | $11.72B | 31.4% | 21.2% |
| Biogen(BIIB) | $10.07B | 16.0% | 8.8% |
| Incyte(INCY) | $4.81B | 24.7% | 25.6% |
| United Therapeutics(UTHR) | $3.13B | 40.6% | 19.3% |
| BioMarin Pharmaceutical(BMRN) | $3.09B | 16.8% | 8.6% |
| Fortrea(FTRE) | $2.76B | - | - |
| Neurocrine Biosciences(NBIX) | $2.68B | 16.0% | 14.2% |
| Sarepta Therapeutics(SRPT) | $2.41B | -11.3% | -20.6% |
| Exelixis(EXEL) | $2.29B | 29.6% | 31.4% |
| Moderna(MRNA) | $2.23B | - | -33.4% |
| Halozyme(HALO) | $1.24B | 47.9% | 118.2% |
| Myriad Genetics, Inc.(MYGN) | $837.60M | -15.2% | - |
| Arrowhead Pharmaceuticals(ARWR) | $829.45M | -0.2% | - |
| Harmony Biosciences Holdings, Inc.(HRMY) | $714.73M | 20.4% | - |
| NOVAVAX INC(NVAX) | $682.16M | -27.5% | - |
| Catalyst Pharmaceuticals Partners, Inc.(CPRX) | $491.73M | 33.3% | - |
Data source: SEC EDGAR filings. Financial data may be from the most recent fiscal year.